BioSpace News Archive

Clarity Pharmaceuticals (ASX: CU6) (“Clarity”), a clinical-stage radiopharmaceutical company developing next-generation products to address the growing needs in oncology, is pleased to announce that it has successfully treated its first participant in cohort 2 of the 64Cu/67Cu SARTATE™ neuroblastoma therapy trial (CL04) at the increased dose level of 175MBq/kg body weight.

Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, will participate in the 42nd Annual Cowen Healthcare Conference being held virtually on Monday, March 7, 2022.

The rising demand for the tooth filling and the technology advancement in cosmetic dentistry are some of the primary factors augmenting growth of the global tooth filling material market.

Rheumatic fever is one of the complications associated with strep throat. It occurs as a delayed sequel to group A streptococcal pharyngitis.

Pneumonia is a type of lung infection caused by microorganisms such as bacteria, viruses, fungi, and parasites.

The life sciences sector comprises pharmaceutical, biotech, and health care segments. It is progressively achieving profitable revenues globally.

Sarcoidosis is a rare inflammatory disease characterized by the development of tiny lumps of cells in organs throughout the body.

The development of the global pharmaceutical gelatin market is estimated to be driven by the unique and versatile functional characteristics of gelatin in many pharmaceutical applications.

CANbridge Pharmaceuticals, Inc. announced that CAN108, a treatment for Alagille syndrome, has been approved under the Early and Pilot Implementation Policy in Boao Lecheng International Medical Tourism Pilot Zone in China, which will allow it to be imported and used as an urgently needed drug in the zone.

Soft tissue retractors help enhance the view and illumination at a surgical site during various surgeries such as general surgery and minimally invasive procedures.